world

EU drug regulator says it is up to countries to decide how to handle AstraZeneca

4 Comments

European countries should make their own decisions about how to handle the risk of rare blood clots from AstraZeneca's COVID-19 vaccine, based on prevailing infection rates and the availability of alternative vaccines, the EU drugs regulator said on Wednesday.

Several countries in Europe have announced restrictions on the use of the AstraZeneca vaccine in younger people, after a link was found to very rare blood clots, mostly in women under 60 years of age within two weeks of vaccination.

Italy was the latest to change its policy on Wednesday, saying that from now on it would recommend the use of AstraZeneca only for those over the age of 60.

But the European Medicines Agency (EMA) held back from issuing guidelines, saying countries would have to assess the balance of risks themselves, based on local conditions that vary widely across the bloc.

"We try to provide as much information as possible on the benefits and the risks we have identified, and based on that and the pandemic situation in a member state - the infection rate, the availability of different vaccines - the different member states can take different decisions on who to vaccinate," EMA Executive Director Emer Cooke told a briefing.

Cooke said the risk of dying from COVID-19 was "much greater" than the risk of mortality from rare side effects.

"It is very important that we use the vaccines we have to try and beat this pandemic," she said.

Sabine Straus, chair of the EMA's safety committee, said side-effects were not unexpected as vaccines were rolled out on a large scale.

The EMA has received reports of 169 cases of a rare brain blood clot known as cerebral venous sinus thrombosis (CVST), as of April 4, Straus said. That's out of 34 million doses of the shot administered in the European Economic Area.

There have also been three cases of blood clots with low platelets after the use of the Johnson & Johnson shot, Peter Arlett, head of data analytics and methods task force, said. Experts told Reuters it was too early to say whether these events were connected to the vaccine.

© Thomson Reuters 2021.

©2021 GPlusMedia Inc.

4 Comments
Login to comment

Several countries in Europe have announced restrictions on the use of the AstraZeneca vaccine in younger people, after a link was found to very rare blood clots, mostly in women under 60 years of age within two weeks of vaccination.

While the risk is likely real, keep in mind that the risk of blood clots from birth control pills is much higher.

The bottom line is that the benefits of the vaccine far outweigh the risks.

https://www.openaccessgovernment.org/risk-of-blood-clots/106257/

2 ( +2 / -0 )

An indirect acknowledgement that there are issues with it.And for you to proceed at your own risk.

1 ( +1 / -0 )

The AZ shot is poison.

-1 ( +0 / -1 )

The AZ shot is poison.

Delirium

0 ( +0 / -0 )

Login to leave a comment

Facebook users

Use your Facebook account to login or register with JapanToday. By doing so, you will also receive an email inviting you to receive our news alerts.

Facebook Connect

Login with your JapanToday account

User registration

Articles, Offers & Useful Resources

A mix of what's trending on our other sites